Clinical Trial Update: Hydraderm for Androgenic Alopecia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of Hydraderm for androgenetic alopecia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Hydraderm

Snippet

Sponsor: University of Minnesota | Conditions: Androgenic Alopecia | Phase 4 | Status: WITHDRAWN